Bloomberg - An interim analysis of Avastin as a treatment for colorectal cancer and two Phase 3 studies of Rituxan for rheumatoid arthritis may also spur volatility, Goldman derivative strategists Maria Grant and John Marshall wrote in a note to clients ...